Trachoma is one of the major causes of preventable blindness worldwide. In Australia it is solely a disease of Aboriginal people. Trachoma in non-indigenous Australians has been eradicated earlier this century, however, is still prevalent among Aboriginal communities. Poor living condition, lack of access to water supply and sanitation, living in a crowded and unhealthy environment are the main causes of trachoma in Indigenous Australians. The World Health Organization (WHO) has initiated Global Alliance for the Elimination of Trachoma by the year 2020 (GET2020). The alliance has adopted the "SAFE" (Surgery, Antibiotic distribution, Facial cleanliness and Environmental improvements) strategy to eliminate trachoma in endemic countries. In Australia, the National Trachoma Surveillance and Reporting Unit (NTSRU) was established in 2006 and ever since has been providing high quality surveillance data on national trachoma burden. In 2009, the Australian Government made a commitment investment of $16 million over a 4-year period to eliminate trachoma from Australia. Today, promising success has been achieved in surveillance and management of trachoma using the SAFE strategy. But the ultimate elimination of the disease would require a long-term political commitment founded, inter alia, on multi-sectoral collaboration, targeted research, and community engagement.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2174/1871526515999150320160246 | DOI Listing |
Commun Dis Intell (2018)
January 2025
The Kirby Institute, UNSW Sydney, Australia.
Australia is the only high-income country where trachoma has been endemic, defined as an overall trachoma prevalence in Aboriginal and Torres Strait Islander children aged 5-9 years of 5% or more. The Australian Government funds the National Trachoma Surveillance and Reporting Unit to collate and analyse trachoma prevalence data and control strategies annually. This report presents data submitted from 2014 to 2022.
View Article and Find Full Text PDFInt J Ophthalmol
January 2025
Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Eye Diseases, Shanghai 200080, China.
Aim: To assess the possibility of using different large language models (LLMs) in ocular surface diseases by selecting five different LLMS to test their accuracy in answering specialized questions related to ocular surface diseases: ChatGPT-4, ChatGPT-3.5, Claude 2, PaLM2, and SenseNova.
Methods: A group of experienced ophthalmology professors were asked to develop a 100-question single-choice question on ocular surface diseases designed to assess the performance of LLMs and human participants in answering ophthalmology specialty exam questions.
PLoS Negl Trop Dis
January 2025
International Centre for Eye Health, Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Background: We aimed to determine the household distribution and viability of Chlamydia trachomatis (Ct) from the eyes, face, and hands during the initial two visits of a year-long fortnightly cohort study in geographically defined adjacent households.
Methods/findings: We enrolled 298 individuals from 68 neighbouring households in Shashemene Woreda, Oromia, Ethiopia. All individuals above 2 years of age residing in these households were examined for signs of trachoma.
Trop Med Int Health
January 2025
Trachoma Control Program, The Carter Center, Atlanta, Georgia, USA.
Background: Trachoma is targeted by the World Health Organization (WHO) for elimination as a public health problem by 2030. Trachoma impact surveys using standardised methodology are recommended to monitor progress towards elimination and to determine eligibility for continued surgery, antibiotics, facial cleanliness, and environmental improvement (SAFE) interventions. From 2007 to 2015, four counties of Eastern Equatoria State, South Sudan, received three to five rounds of mass drug administration with antibiotics.
View Article and Find Full Text PDFBMC Infect Dis
January 2025
Ethiopia Ministry of Health, Addis Ababa, Ethiopia.
Background: Following interventions to eliminate trachoma in the Afar region of Ethiopia, our goal was to reassess the prevalence of trachomatous trichiasis (TT) and trachomatous inflammation-follicular (TF) at the woreda level, and to identify factors associated with the disease.
Methods: Cross-sectional community-based surveys were conducted in 26 trachoma-endemic woredas, employing a standardized approach. Households were selected as the secondary sampling unit.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!